Gen Ilac
Investor profile
Corporate
Gen Ilac has backed 2 European tech companies across 2 funding rounds in 2021, joining rounds totalling €11M. Most active in Healthtech. Data as of Nov 2026.
Also recorded as: GEN İlaç
Deals
2
distinct rounds
Companies
2
backed
Active span
2021
1 yr
Total round €
€11M
sum of rounds joined
Deals by year
distinct rounds / yearGen Ilac — deals by year — interactive chart.
Data table
| Gen Ilac — deals by year | |
|---|---|
| 2021 | 2 |
Top sectors
by dealsGen Ilac — top sectors — interactive chart.
Data table
| Gen Ilac — top sectors | |
|---|---|
| Healthtech | 2 |
Stages
by dealsGen Ilac — stages — interactive chart.
Data table
| Gen Ilac — stages | |
|---|---|
| Seed | 1 |
| Series A | 1 |
Countries
by dealsGen Ilac — countries — interactive chart.
Data table
| Gen Ilac — countries | |
|---|---|
| Switzerland | 1 |
| Türkiye | 1 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared roundsPortfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| RS Research | Türkiye | 1 | €11M |
| Galventa | Switzerland | 1 | €696k |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| RS Research | Series A | €11M | 2021-12 |
| Galventa | Seed | €696k | 2021-10 |